MPH Quiz. Melanoma Case 1

Similar documents
The Diagnosis of Cancer in the Pathology Laboratory

OBJECTIVES By the end of this segment, the community participant will be able to:

Frozen Section Diagnosis

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

7 th Edition Staging. AJCC 7 th Edition Staging. Disease Site Webinar. Melanoma of Skin. Overview. This webinar is sponsored by

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

GENERAL CODING. When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis.

Understanding your pathology report

How CanCer becomes critical in the claims

Male. Female. Death rates from lung cancer in USA

How to report Upper GI EMR/ESD specimens

Melanoma. Edward Buckingham, M.D. Combined Plastics & Otolaryngology Conference The University of Texas Medical Branch September 6, 2000

Something Old, Something New.

Lesions, and Masses, and Tumors Oh My!!

YOUR LUNG CANCER PATHOLOGY REPORT

A912: Kidney, Renal cell carcinoma

An individual is considered an incident case only once per lifetime.

HKCPath Anatomical Pathology Peer Review and Scores : PDF version for download

III II II III. ge: /ears sex: Male Access

Policy Wording. Together, all the way.

Your Guide to the Breast Cancer Pathology Report

Coding Dermatology Procedures. Presented by: Betty A Hovey Director, ICD-10 Development and Training AAPC

Melanoma The Skin Understanding Cancer

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.

Kidney Cancer OVERVIEW

General Rules SEER Summary Stage Objectives. What is Staging? 5/8/2014

Directly Coded Summary Stage Is Back

Report series: General cancer information

BREAST CANCER PATHOLOGY

Thyroid and Adrenal Gland

CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY

Lesions, and Masses,

Breast cancer close to the nipple: Does this carry a higher risk ofaxillary node metastasesupon diagnosis?

Breast Cancer: from bedside and grossing room to diagnoses and beyond. Adriana Corben, M.D.

CARDCARE PROTECTOR CERTIFICATE OF INSURANCE

Chapter 2 Staging of Breast Cancer

EMR Can anyone do this?

Update on Mesothelioma

National Program of Cancer Registries Education and Training Series. How to Collect High Quality Cancer Surveillance Data

Cervical Cancer The Importance of Cervical Screening and Vaccination

Breast Cancer. Sometimes cells keep dividing and growing without normal controls, causing an abnormal growth called a tumor.

Evaluation and Management of the Breast Mass. Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003

TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD

BERGEN COMMUNITY COLLEGE DIAGNOSTIC MEDICAL SONOGRAPHY PROGRAM Division of Health Professions DMS 213 SYLLABUS

Information Model Requirements of Post-Coordinated SNOMED CT Expressions for Structured Pathology Reports

NEOPLASMS C00 D49. Presented by Jan Halloran CCS

ATLAS OF HEAD AND NECK PATHOLOGY THYROID PAPILLARY CARCINOMA

SEMESTER VI 3 RD YEAR PATHOLOGY KIDNEY TUMORS

HAVE YOU BEEN NEWLY DIAGNOSED with DCIS?

Title: Immunohistochemical staining of radixin and moesin in prostatic adenocarcinoma

Neoplasms of the LUNG and PLEURA

Multiple Primary and Histology Site Specific Coding Rules KIDNEY. FLORIDA CANCER DATA SYSTEM MPH Kidney Site Specific Coding Rules

Multiple Primary and Histology Coding Rules

Cancer of the Exocrine Pancreas, Ampulla of Vater and Distal Common Bile Duct Proforma

Nicole Kounalakis, MD

Clear Cell Sarcoma of the Foot: A Case Report of Malignant Melanoma of Soft Parts

BAP1 germline mutations A new Cutaneous Nevus Melanoma Syndrome. Thomas Wiesner

PNL2 MELANOCYTIC MARKER IN IMMUNOHISTOCHEMICAL EVALUATION OF PRIMARY MUCOSAL MELANOMA OF THE HEAD AND NECK

PROPERTY OF ELSEVIER SAMPLE CONTENT - NOT FINAL

These parameters cannot, at the present time, be determined by non-invasive imaging techniques.

Excision of Lesions. Brenda Chidester-Palmer CPC, CPC-I, CEMC, CASCC, CCS-P. All Rights Reserved. Objectives

Early Prostate Cancer: Questions and Answers. Key Points

why? 75 percent The percentage of healthy individuals over age 40 who will become critically ill at some time in the future. 3

Breast Cancer. The Pathology report gives an outline on direction of treatment. It tells multiple stories to help us understand the patient s cancer.

METASTATIC CLEAR CELL RENAL CELL CARCINOMA TO THE SUBCUTANEOUS AREA IN ILLIAC FOSSA AND ADRENAL GLAND WITHOUT AN IDENTIFIABLE PRIMARY TUMOR

CHAPTER 2. Neoplasms (C00-D49) March MVP Health Care, Inc.

MALE BREAST CANCER - CASE REPORT AND BRIEF REVIEW

THYROID CANCER. I. Introduction

Learning Luncheon 7: Endoscopic Mucosal Resection: When, Where and How?

Renal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD

Frequently Asked Questions About Ovarian Cancer

Cancer of the Cervix

Effusions: Mesothelioma and Metastatic Cancers

Lung Cancer. Ossama Tawfik, MD, PhD Professor, Vice Chairman Director of Anatomic &Surgical Pathology University of Kansas School of Medicine

Understanding. Pancreatic Cancer

Efficient Tumor Immunohistochemistry A Differential Diagnosis-Driven Approach

Current Status and Perspectives of Radiation Therapy for Breast Cancer

Integumentary System Individual Exercises

Oklahoma Facts CPT. Definitions. Mohs Micrographic Surgery. What Does That Mean? Billing and Coding for Mohs Surgery

Hereditary Multifocal Breast Cancer. Farin Amersi M.D., F.A.C.S Division of Surgical Oncology Department of Surgery Cedar Sinai Medical Center

Renal Tumors with Eosinophilic Cytoplasm: 2013 Classification. Jesse K. McKenney, MD Associate Head, Surgical Pathology

FRIEND TO FRIEND CPT CODES Diagnostic digital breast tomosynthesis, unilateral (list separately in addition to code for primary procedure)

Traumatic Primary Eyelid and Facial Laceration Repair. Riva Lee Asbell Philadelphia, PA

Medullary Renal Cell Carcinoma Case Report

Prostate Cancer In-Depth

Introduction Breast cancer is cancer that starts in the cells of the breast. Breast cancer happens mainly in women. But men can get it too.

PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT

Breast Imaging Made Brief and Simple. Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA

Introduction. Case History

Ductal carcinoma in situ (DCIS)

9. Discuss guidelines for follow-up post-thyroidectomy for cancer (labs/tests) HH

The Role of Genetic Testing in the Evaluation of Thyroid Nodules. Thyroid Cancer and FNA. Thyroid Cancer. Pure Follicular Cancers.

Polyps. Hyperplasias. CAP 2011: Course AP104. The High Risk Benign Endometrium. Mutter and Nucci 1

Diagnosis of Mesothelioma Pitfalls and Practical Information

The TV Series. INFORMATION TELEVISION NETWORK

Transcription:

MPH Quiz Surigcal Pathology Report May 5, 2007 Melanoma Case 1 Clinical History: Shave biopsies of a tumor on the left cheek and another in the mid chin area. Tumors are approximately 5 cm from each other. Patient now presents for a wide excision of each tumor. Specimen: A. Left cheek B. Chin A. Skin, left cheek, shave biopsy: Invasive malignant melanoma, anaplastic, nodular type with epithelioid and spindle cell features. Clark's level: IV. Breslow thickness: 2.05 mm. Ulceration: Present. Satellites: Present. B. Skin, mid chin, invasive malignant epithelioid cell melanoma. Clark's level: II. Breslow thickness: 1.05 mm. Ulceration: Present. Satellites: None. END Melanoma Case 1 1

Surgical Pathology Report October 1, 2007 Specimen: A. Left upper quadrant abdomen B. Left lower chest wall Melanoma Case 2 SURGICAL PATHOLOGY REPORT #1 A. Skin of abdomen, shave biopsy: Malignant melanoma in situ, lentigo maligna type confined to epidermis (Clark's level I). Features of regression not present. B. Skin of left chest wall, punch biopsy: Melanoma in situ arising in association with a congenital melanocytic nevus, compound type with features of regression. Melanoma confined to epidermis (Clark's level I). Comment: Both biopsies consist of a melanocytic proliferation with an intraepidermal component that shows features of melanoma in situ including pagetoid migration of atypical melanocytes. In the biopsy from "left chest wall", there is a dermal melanocytic component that is composed primarily of small melanocytes and is interpreted as a preexisting nevus. Surgical Pathology Report October 14, 2007 Specimen: A. Left abdomen B. Left chest wall SURGICAL PATHOLOGY REPORT #2 A. Skin of abdomen, left, wide excision: Cicatrix. No residual malignant melanoma in situ is identified. B. Skin of chest wall, wide excision: Cicatrix. No residual malignant melanoma in situ is identified. END Melanoma Case 2 2

Surgical Pathology Report April 1, 2007 Melanoma Case 3 SURGICAL PATHOLOGY REPORT Clinical History: Labeled growth behind the right ear is a 2.8 x 1.7 x 0.8 cm ellipse of rubbery tan skin and subcutaneous tissue. Suture indicates the superior resection margin. Specimen(s): Growth behind right ear Microscopic Examination: The ulcerating tumor is a nodular melanoma, spindle cell variant, which extends deeply into the reticular dermis. Resection margins are not involved by tumor. No radial growth phase is identified. The elongated tumor cells, arranged in streaming fascicles, show a high mitotic rate of 12/mm 2. No tumor-infiltrating lymphocytes or evidence of regression are identified. All resection margins are free of tumor. No angiolymphatic invasion is noted. No co-existing nevus is seen. A panel of immunostains shows marked positivity of the tumor cells for S100 and desmin and weak positivity for actin. Tumor cells are negative for HMB45 and AE1/3 by this method. Skin, behind right ear: Nodular melanoma, spindle cell variant, excised Summary of Malignant Neoplasm: Skin-Malignant Melanoma Histopathologic subtype: Nodular, spindle cell variant Clark s level: IV Breslow thickness (mm): 8.65 mm Margins: Not involved (0.2 cm to closest margin) Ulceration: Yes Mitotic rate (dermal component): 12/mm 2 Vascular or lymphatic invasion: Not identified Perineural invasion: Not identified Tumor infiltrating lymphocytes (vertical growth phase only): Not present Regression: Not identified Satellitosis (in-transit dermal metastases): Not identified END Melanoma Case 3 3

Surgical Pathology Report August 30, 2007 Specimen(s): A. Left medial shin lesion B. Left anteromedial thigh lesion Melanoma Case 4 SURGICAL PATHOLOGY REPORT Gross Examination: The specimen is received in two parts (Part A, Part B): Part A, designated left medial shin lesion, is a formalin-fixed, wrinkled-surfaced, 3.0 x 2.6 x 0.5-cm disc of pale tan skin. On the surface are two irregular, slightly roughened, pink-gray lesions. One is 0.6, the other 1.5 cm in greatest dimension. The specimen is inked and sectioned. Part B, designated left anteromedial thigh lesion, is a formalin-fixed, wrinkled-surfaced, 3.0 x 2.8 x 0.7-cm disc of pinkish-tan skin. On the surface is an irregular, slightly raised, 1.1-cm in greatest dimension, pinkish-gray lesion. The specimen is inked and sectioned. Microscopic Examination: A. Sectioning the lesion shows within the epidermis irregular nests of atypical melanocytes. In the current material, the lesion appears as in-situ melanoma with evidence of "regression". B. Sectioning the lesion shows within the epidermis irregular nests of atypical melanocytes. These cells possess large nuclei and abundant pale cytoplasm. In the current material, the lesion appears as in-situ melanoma with evidence of "regression". A. Left medial shin lesion: In-situ melanoma, appearing excised B. Left anteromedial thigh lesion: In-situ melanoma, appearing excised END Melanoma Case 4 4

Surgical Pathology Report March 28, 2007 Specimen: Abdomen and back Melanoma Case 5 SURGICAL PATHOLOGY REPORT #1 Immunohistochemical procedures are done using a standard LSAB (Labeled StreptAvidin Biotin) Kit, DAB as a detection reagent on a DAKO immunostainer. Procedure and dilutions of antibodies are on file. The standard immunohistochemical protocol was followed. Laboratory extrinsic controls for the antibodies tested exhibited appropriate staining. Antibody 1: S100 Interpretation: Negative Vendor: NDAKO Pretreatment: none % of Cells: 0 Intrinsic controls were positive Antibody 2: HMB 45 Interpretation: Negative Vendor: DAKO Pretreatment: none % of Cells: 0 Intrinsic controls were not evaluable A. Skin lesion, abdomen, excision consult diagnosis: Severe melanocytic dysplasia arising in a congenital melanocytic nevus. This is of indeterminate malignant potential (traumatic scar and invasive melanocytic lesion cannot be excluded).. B. Skin lesion, back, excision consult diagnosis: Malignant melanoma, superficial spreading type having level III invasion (Clark classification). END Melanoma Case 5 5

MPH Quiz Questions Case 1 1. Which mulitple primary rule would be used for case 1? a. M1 Single primary b. M3 Multiple Primaries c. M4 Multiple Primaries d. M8 Single Primary 2. Which answer below indicates the histology for each primary in case 1? a. Nodular melanoma, NOS (8721/3) b. Epithelioid cell melanoma (8771/3) c. Epithelioid and spindle cell melanoma, mixed (8770/3) d. Spindle cell melanoma (8772/3) 3. Which histology rule(s) would be used for case 1 (circle all that apply)? a. H3 b. H4 c. H9 d. H10 Case 2 4. Which mulitple primary rule would be used for case 2? a. M1 Single primary b. M2 Single primary c. M5 Multiple Primaries d. M8 Single Primary 5. Which answer below indicates the histology(ies)in case 2? a. Melanoma in situ (8720/2) b. Lentigo maligna melanoma, in situ (8742/2) c. Melanoma in situ arising in a congenital melanocytic nevus (8761/2) d. Spindle cell melanoma (8772/3) 6. Which histology rule(s) would be used for case 2 (circle all that apply)? a. H3 b. H4 c. H9 d. H10 Case 3 7. Which mulitple primary rule would be used for case 3? a. M1 Single primary b. M2 Single primary c. M5 Multiple Primaries d. M8 Single Primary 8. Which answer below indicates the histology(ies)in case 3? a. Nodular melanoma, NOS (8721/3) b. Epithelioid cell melanoma (8771/3) c. Malignant melanoma (8720/3) d. Spindle cell melanoma (8772/3) 6

9. Which histology rule(s) would be used for case 3 (circle all that apply)? a. H3 b. H4 c. H9 d. H10 Case 4 10. Which mulitple primary rule would be used for case 4? a. M1 Single primary b. M2 Single primary c. M5 Multiple Primaries d. M8 Single Primary 11. Which answer below indicates the histology(ies)in case 4? a. Melanoma in situ (8720/2) b. Melanoma in situ with features of regression (8723/2) c. Melanoma arising in a congenital melanocytic nevus (8761/3) d. Spindle cell melanoma (8772/3) 12. Which histology rule(s) would be used for case 4 (circle all that apply)? a. H3 b. H4 c. H9 d. H10 Case 5 13. Which mulitple primary rule would be used for case 5? a. M1 Single primary b. M2 Single Primary c. M4 Multiple Primaries d. M8 Single Primary 14. Which histology rule(s) would be used for case 1 (circle all that apply)? a. H3 b. H4 c. H9 d. H10 15. Which answer below indicates the histology(ies)in case 3? a. Nodular melanoma, NOS (8721/3) b. Epithelioid cell melanoma (8771/3) c. Malignant melanoma (8720/3) d. Superficial spreading melanoma (8743/3) 7

Quiz 2 New Data Items Case 1 SURGICAL PATHOLOGY REPORT Note: This case is One Primary with Multiple Tumors Reported as Single Primary Surgical Pathology Report January 4, 2007 Surgical Specimen: Bladder, cystectomy Cystectomy A. Poorly differentiated transitional cell carcinoma of the bladder trigone, 3.2cm, extending through muscular wall, margins free of tumor. B. Two separate, 1.0cm moderately differentiated papillary transitional cell carcinomas of the bladder within the dome of the bladder. END New Data Items Case 1 8

New Data Items - Case 2 SURGICAL PATHOLOGY REPORT Note: This case is One Primary with Multiple Tumors Reported as Single Primary Surgical Pathology Report July 27, 2007 Specimen: Left breast, mastectomy Breast, left, mastectomy 1. Widespread, multicentric infiltrating lobular carcinoma associated with extensive multicentric lobular carcinoma in situ - Diameter of aggregate tumor foci greater than 5.0cm - Lymphovascular invasion not seen - Estrogen/Progesterone receptor and HER2/NEU expression assays pending 2. Infiltrating ductal carcinoma, grade 1 - Tumor diameter 1.5cm - Small amount of low-grade ductal carcinoma in situ - Invasive or in situ tumor not seen to touch inked surgical margins - Lymphovascular invasion not seen - Estrogen/Progesterone receptor and HER2/NEU expression assays pending END New Data Items Case 2 9

Surgical Pathology Report June 2, 2007 Specimen (s) received: A. Prostate right base x 2 B. Prostate right middle x 2 C. Prostate right apex x 2 D. Prostate left base x 2 E. Prostate left middle x 2 F. Prostate left apex x 2 New Data Items - Case 3 SURGICAL PATHOLOGY REPORT #1 Prostate, biopsies as designated: focal atypical small glands suspicious for minimal prostatic adenocarcinoma associated with high grade prostatic intraepithelial neoplasia. Surgical Pathology Report October 14, 2007 Specimen (s) received: Prostatectomy New Data Items Case 3 SURGICAL PATHOLOGY REPORT #2 Prostate, prostatectomy: prostatic adenocarcinoma, well differentiated, Gleason 2+3=5 END New Data Items Case 3 10

Surgical Pathology Report June 2, 2007 Clinical History: Polyp Specimen (s) received: A. Colon, sigmoid polyp, polypectomy B. Colon, biopsies New Data Items - Case 4 SURGICAL PATHOLOGY REPORT Gross Examination: A. Received in formalin, labeled polyp is a piece of brown soft tissue compatible with mucosa. The tissue measures approximately 1.0 x 1.0 x 0.4 cm in greatest length. The tissue is submitted in toto in one cassette. B. Received in formalin, labeled areas around polyp, are multiple pieces of brown sift tissue compatible with mucosa. The largest tissue approximately 0.3 x 0.2 x 0.1 cm in greatest diamter. The tissues are submitted in toto in one cassette. A. Colon, sigmoid, polyp, polypectomy: Tubular adenoma with focus suspicious for invasive adenocarcinoma. B. Colon biopsies: fragments of colonic mucosa with no specific pathologic change. No dysplasia seen. Notes/Comments: The foci suspicious for invasive adenocarcinoma are characterized by groups of glands invading below the apparent muscularis mucosa. These glands come within 1 mm of the deep cauterized margin. These glands in addition arise from a tubular adenoma with both architectural and cytologic features of high grade dysplasia. A more definitive diagnosis of invasive adenocarcinoma is not possible on the current material given the cautery artifact. END New Data Items Case 4 11

New Data Items - Case 5 RENAL ULTRASOUND Renal Ultrasound October 16, 2007 Reason for Exam: Patient with chronic hypertension and more recently right flank pain for the past two months, increasing in severity. Renal Ultrasound: 5cm mass in the upper pole right kidney, suspicious for renal cell carcinoma Assessment: Probable renal cell carcinoma, however benign cyst is included in the differential diagnosis. New Data Items Case 5 SURGICAL PATHOLOGY REPORT Surgical Pathology Report October 17, 2007 Specimen: Right kidney, radical nephrectomy Final diagnosis: Adenocarcinoma, probable clear cell type of renal cell carcinoma END New Data Items Case 5 12

Worksheet for New Data Items 1. Quiz question a. Ambiguous Terminology b. Date of Conclusive Terminology / / c. Multiplicity Counter d. Date of Multiple Tumors / / e. Type of Multiple Tumors 2. Quiz question a. Ambiguous Terminology b. Date of Conclusive Terminology / / c. Multiplicity Counter d. Date of Multiple Tumors / / e. Type of Multiple Tumors 3. Quiz question a. Ambiguous Terminology b. Date of Conclusive Terminology / / c. Multiplicity Counter d. Date of Multiple Tumors / / e. Type of Multiple Tumors 4. Quiz question a. Ambiguous Terminology b. Date of Conclusive Terminology / / c. Multiplicity Counter d. Date of Multiple Tumors / / e. Type of Multiple Tumors 5. Quiz question a. Ambiguous Terminology b. Date of Conclusive Terminology / / c. Multiplicity Counter d. Date of Multiple Tumors / / e. Type of Multiple Tumors 13

Collaborative Stage Quiz 1. The patient had an excisional biopsy of a melanoma of the skin of the forehead. The operative report documented the tumor size as 3.0 cm, and the pathology report documented the tumor size as 2.5. The code for CS tumor size is: a. 025 b. 030 c. 993 d. 999 2. An excisional biopsy of skin lesion of the left shin diagnosed nodular melanoma, Clark s level IV, papillary-reticular dermis invaded, and 0.8 mm thickness. The CS extension code is: a. 20 b. 30 c. 40 d. 99 3. In the example above the codes for CS SSF1 and CS SSF2 are: a. 008; 000 b. 008; 999 c. 080; 000 d. 040; 999 4. Liver lesion was biopsied and diagnosed metastatic melanoma. No skin lesions were identified. CS extension and CS mets at dx codes are: a. 99; 40 b. 95; 99 c. 95; 44 d. 95; 40 5. Patient is diagnosed with a melanoma on the upper lip with a metastatic lesion on the skin above the lip 1.5 cm from the lip lesion. One buccinator lymph node was excised and metastatic. The CS lymph nodes code is: a. 12 b. 14 c. 18 d. 22 14

Melanoma Treatment Quiz 1. A patient had an excisional biopsy performed at another facility then came to your facility for a wide excision of the lesion, margins less than 1 cm. What surgery code would you use? a. 27 b. 30 c. 45 d. 46 2. A patient had a melanoma and a shave type biopsy performed at another facility. They then went to your facility for a wide excision of the lesion, margins less than 1cm. What is Surgery of the primary site? a. 30 b. 31 c. 45 d. 46 3. For melanoma with amputation of the toe, but with no margins specified, how is surgery coded? a. 30 b. 31 c. 45 d. 46 4. A malignant melanoma was removed with close margins on a punch biopsy. It was followed by re-excision that showed not residual. The punch biopsy should be coded as a diagnostic procedure and the re-excision codes as surgery to the primary site. a. True b. False 5. Interferon-alpha is coded as a: a. Chemotherapy b. Hormone c. Biologic Response Modifier d. Other Treatment 15